首页> 美国卫生研究院文献>Frontiers in Genetics >Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates
【2h】

Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates

机译:系统化学遗传学为基础的药物发现:优先针对以多种/可靠的疾病相关基因为目标的药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genetic disease genes are considered a promising source of drug targets. Most diseases are caused by more than one pathogenic factor; thus, it is reasonable to consider that chemical agents targeting multiple disease genes are more likely to have desired activities. This is supported by a comprehensive analysis on the relationships between agent activity/druggability and target genetic characteristics. The therapeutic potential of agents increases steadily with increasing number of targeted disease genes, and can be further enhanced by strengthened genetic links between targets and diseases. By using the multi-label classification models for genetics-based drug activity prediction, we provide universal tools for prioritizing drug candidates. All of the documented data and the machine-learning prediction service are available at SCG-Drug ().
机译:遗传疾病基因被认为是有希望的药物靶标来源。大多数疾病是由一种以上的致病因素引起的。因此,有理由认为靶向多种疾病基因的化学药物更可能具有所需的活性。对病原体活性/药物易性与靶基因特性之间的关系进行全面分析后,即可得出结论。随着靶向疾病基因数量的增加,药物的治疗潜力会稳步增加,并且可以通过增强靶标与疾病之间的遗传联系来进一步增强其治疗潜力。通过将多标签分类模型用于基于遗传学的药物活性预测,我们提供了优先考虑候选药物的通用工具。所有记录的数据和机器学习预测服务均可从SCG-Drug()获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号